Clinical Trials Browser

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT06165900 2024-01-03

Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC

Phase 2 Recruiting

136 enrolled

Breast

Breast Neoplasms

NCT05569811 2023-09-21

VALENTINE

Phase 2 Active not recruiting

120 enrolled

Breast

Breast Neoplasms

NCT05862610 2023-07-24

The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC

Phase 2 Not yet recruiting

150 enrolled

Breast

Breast Neoplasms

NCT02679040 2023-07-03

HIST-RIC

Phase 2 Unknown

101 enrolled

Breast

Breast Neoplasms

NCT05840068 2023-05-03

IGF Level in Breast Cancer Patients Treated With Metformin

Phase 4 Completed

107 enrolled

Breast

Breast Neoplasms

NCT00004935 2023-04-18

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Phase 3 Terminated

175 enrolled

Breast

Breast Neoplasms

NCT04435964 2023-03-24

G-DEFINER

Completed

247 enrolled

BreastDermatologicHead & NeckThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Urogenital Neoplasms

NCT05680194 2023-01-11

EEBC

Unknown

1,000 enrolled

Breast

Breast Neoplasms

NCT03386162 2022-11-28

SAFIR-PI3K

Phase 2 Terminated

31 enrolled

Breast

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT05341141 2022-06-13

Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy

Phase NA Recruiting

102 enrolled

Breast

Breast Neoplasms

NCT02000596 2022-05-27

1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

Phase 2 Terminated

2 enrolled 7 charts

Breast

Breast Neoplasms

NCT05346861 2022-04-26

Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab

Phase 3 Unknown

240 enrolled

Breast

Breast Neoplasms

NCT05253066 2022-02-23

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

Phase 2/3 Unknown

130 enrolled

Breast

Breast Neoplasms

NCT04143282 2021-12-07

Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment

Phase 2 Completed

250 enrolled

Breast

Breast Neoplasms

NCT02535221 2021-11-29

Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

Phase 3 Recruiting

234 enrolled

Breast

Breast Neoplasms

NCT03908528 2021-10-11

Alpha-Lipoic Acid in Breast Cancer Patients

Phase NA Completed

64 enrolled

Breast

Breast Neoplasms

NCT04882371 2021-05-11

Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer

Completed

88 enrolled

Breast

Breast Neoplasms

NCT04495387 2021-04-27

Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy

Unknown

100 enrolled

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT04559308 2020-09-22

The Effect of Metformin on Breast Cancer Patients

Phase 2 Unknown

80 enrolled

Breast

Breast Neoplasms

NCT02251353 2020-02-21

IMET

Unknown

300 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01104935 2019-10-21

RESPECT

Phase 3 Completed

275 enrolled

Breast

Breast Neoplasms

Clinical Trials

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

FACT-TN

Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

ECLECTIC

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

AVR-CHEMO

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

PTX / BC

Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Clinical Observational Studies:Integrative TCM and Western Medicine for Breast Cancer

Arsenous Acid for Refractory Triple-Negative Breast Cancer

SENIOR

A Study on the Efficacy and Safety of IPyC for HER2+ MBC

Barriers to Therapeutic Exercise in Breast Cancer Patients Before, During, and After Chemotherapy

Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer

Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP

KENDO

PADMA

Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy

Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results

PATRICIA II

Rainbow

CHANCES

Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC

VALENTINE

The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC

HIST-RIC

IGF Level in Breast Cancer Patients Treated With Metformin

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

G-DEFINER

EEBC

SAFIR-PI3K

Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy

1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment

Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

Alpha-Lipoic Acid in Breast Cancer Patients

Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer

Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy

The Effect of Metformin on Breast Cancer Patients

IMET

RESPECT